PMID: 2107997Mar 1, 1990Paper

Ifosfamide and mesna

Clinical Pharmacy
S E Schoenike, W J Dana

Abstract

The chemistry, pharmacology, pharmacokinetics, and adverse effects of ifosfamide and mesna are described separately, followed by a discussion of the adverse effects of concurrent ifosfamide and mesna, the clinical spectrum of ifosfamide, and the dosage and administration of the two drugs. Ifosfamide, an active analogue of cyclophosphamide, differs from other direct alkylating substances in that it requires biotransformation in the liver before it can exert its alkylating effects. The bioavailability of ifosfamide after oral administration exceeds 95%. The adverse effects of ifosfamide include hematologic, urinary tract, GI tract, and CNS toxicity. Mesna is a thiol compound designed to function as a regional detoxificant of urotoxic oxazaphosphorine cytostatics such as ifosfamide. The drug is rapidly oxidized in the plasma to its dimeric form, dimesna, one third of which is converted back to mesna by glutathione reductase. The mean total urinary availability of mesna administered orally is 76%. Mesna may produce gastrointestinal and allergic reactions. The adverse effects of concurrent ifosfamide and mesna include urinary tract and renal toxicity. Although current FDA-approved labeling is limited to refractory germ cell testicul...Continue Reading

Citations

Nov 4, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gerald SchwerdtMichael Gekle
Sep 25, 2014·International Urology and Nephrology·Ibrahim KelesMehmet Emin Buyukokuroglu
Dec 6, 2012·Oxidative Medicine and Cellular Longevity·Mohamed M Sayed-AhmedOthman A Al-Shabanah
Mar 10, 2001·Clinical Pharmacokinetics·T KerbuschJ H Beijnen
Jul 29, 2003·Clinical Pharmacokinetics·Dirk Schrijvers
Apr 7, 2007·Anti-cancer Drugs·Kyohei TakahashiYukio Fujimoto
Jan 21, 2010·Anti-cancer Drugs·Pol SpecenierJan B Vermorken
Nov 14, 2003·Reproductive Toxicology·Petros YpsilantisConstantinos Simopoulos
Apr 1, 1997·Japanese Journal of Clinical Oncology·Y M ChenJ Whang-Peng
May 4, 1995·The New England Journal of Medicine·G B ZulianB Maton
Apr 8, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·A PaciF Brion
Nov 17, 2015·Expert Review of Anticancer Therapy·Dahlia SalmanShereen Nabhani-Gebara
Mar 25, 2009·Expert Opinion on Drug Safety·Lauren HanlyGideon Koren
Sep 11, 2008·Scandinavian Journal of Urology and Nephrology·Malcolm LawsonDavid Nicol
Jul 21, 1997·FEBS Letters·T M VisariusB H Lauterburg
Mar 1, 1996·Journal of Pharmaceutical Sciences·G MomerencyE A De Bruijn
Jan 19, 2010·The Journal of Surgical Research·Petros YpsilantisConstantinos Simopoulos
Feb 1, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Francisco Yuri Bulcão MacedoRonaldo A Ribeiro
Nov 22, 2007·European Journal of Pharmacology·Xufang WangTongwen Xu
Nov 27, 2007·Free Radical Biology & Medicine·Jinsong Zhang, Hongjuan Lu
Aug 10, 2007·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Premila AbrahamEmila Sugumar
Dec 3, 2014·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Lydia AschauerPaul Jennings
Mar 16, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·T AjithkumarP Murray
Apr 1, 2006·Chirality·Katarina AleksaGideon Koren
Nov 27, 2008·Journal of Gastroenterology and Hepatology·Petros YpsilantisConstantinos Simopoulos
Feb 17, 2005·European Journal of Pharmacology·Azza El-MedanyGamila El-Medany
Aug 18, 2004·The Journal of Surgical Research·Petros YpsilantisConstantinos Simopoulos
Nov 15, 2014·British Journal of Clinical Pharmacology·Lauren N FaughtKoren Gideon
Feb 28, 2006·The Journal of Surgical Research·Petros YpsilantisConstantinos Simopoulos
Dec 21, 2005·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C DufourO Hartmann
May 7, 2003·The Journal of the American Association of Gynecologic Laparoscopists·Luigi BenassiEugenio Vadora
Feb 9, 2012·International Journal of Surgical Oncology·Kurt Van der SpeetenPaul H Sugarbaker
Oct 4, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Gabriel BaverelAgnès Duplany

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.